Triphosgene → HCID 67996029, 화합물

HRID 1615142노트

반응식

HRID 1615142 반응식
FC1C=C(F)C=CC=1[C@@H](NCCC1(O)CCC2(OCC(C)(C)CO2)CC1)C.ClC(Cl)(OC(=O)OC(Cl)(Cl)Cl)Cl.[F:40][C:41]1[CH:46]=[C:45]([F:47])[CH:44]=[CH:43][C:42]=1[C@@H:48]([N:50]1[CH2:55][CH2:54][C:53]2([CH2:67][CH2:66][C:58]3(OCC(C)(C)C[O:59]3)[CH2:57][CH2:56]2)[O:52][C:51]1=[O:68])[CH3:49]>>[F:40][C:41]1[CH:46]=[C:45]([F:47])[CH:44]=[CH:43][C:42]=1[C@@H:48]([N:50]1[CH2:55][CH2:54][C:53]2([CH2:67][CH2:66][C:58](=[O:59])[CH2:57][CH2:56]2)[O:52][C:51]1=[O:68])[CH3:49]

참가 물질

4

반응물 3

HCID 94429TriphosgeneHCID 67995737HCID 67995737, 화합물HCID 67996352HCID 67996352, 화합물

생성물 1

HCID 67996029HCID 67996029, 화합물

실험 절차

The title compound is prepared from 9-{2-[(S)-1-(2,4-difluoro-phenyl)-ethylamino]-ethyl}-3,3-dimethyl-1,5-dioxa-spiro[5.5]undecan-9-ol and triphosgene following a procedure analogous to that described in Step 4 of Intermediate 2; the crude product, a mixture of the title compound and 3-[(S)-1-(2,4-difluoro-phenyl)-ethyl]-12,12-dimethyl-1,10,14-trioxa-3-aza-dispiro[5.2.5.2]hexadecan-2-one, obtained after that is treated as described in Step 10 of Intermediate 2 to convert the intermediate to the title compound as well. Yield: 30% of theory; LC (method 6): tR=1.10 min; Mass spectrum (ESI+): m/z=324 [M+H]+.

후처리

  1. customobtained after
  2. additionthat is treated

출처 및 근거

ORD 기록
ord-2605127038c247ada4d21a19ace77079
출처 데이터셋
uspto-grants-2014_07
특허 번호
US08765744B2

반응 노트

불러오는 중…